噻吩-2- carboxamide的恶二唑基、吡唑基和噻唑基衍生物抗菌和抗hcv药物的合成。

Q2 Pharmacology, Toxicology and Pharmaceutics
Open Medicinal Chemistry Journal Pub Date : 2017-04-28 eCollection Date: 2017-01-01 DOI:10.2174/1874104501711010038
Ola H Rizk, Omaima G Shaaban, Abeer E Abdel Wahab
{"title":"噻吩-2- carboxamide的恶二唑基、吡唑基和噻唑基衍生物抗菌和抗hcv药物的合成。","authors":"Ola H Rizk,&nbsp;Omaima G Shaaban,&nbsp;Abeer E Abdel Wahab","doi":"10.2174/1874104501711010038","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Three series of pyrazole, thiazole and 1,3,4-oxadiazole, derivatives were synthesized starting from 5-amino-4-(hydrazinocarbonyl)-3-methylthiophene-2-carboxamide <b>(2)</b>.</p><p><strong>Methods: </strong>All compounds were investigated for their preliminary antimicrobial activity. They were proved to exhibit remarkable antimicrobial activity against <i>Pseudomonas aeruginosa</i> with insignificant activity towards Gram positive bacterial strains and fungi.</p><p><strong>Results: </strong><i>In-vitro</i> testing of the new compounds on hepatitis-C virus (HCV) replication in hepatocellular carcinoma cell line HepG2 infected with the virus utilizing the reverse transcription polymerase chain reaction technique (RT-PCR) generally showed inhibition of the replication of HCV RNA (-) strands at low concentration, while, eight compounds; <b>3a</b>, <b>6</b>, <b>7a</b>, <b>7b</b>, <b>9a</b>, <b>9b</b>, <b>10a</b> and <b>11b</b> proved to inhibit the replication of HCV RNA (+) and (-) strands at very low concentration range 0.08-0.36 μg/mL.</p><p><strong>Conclusion: </strong>Compounds <b>7b</b> and <b>11b</b> displayed the highest anti-HCV and antimicrobial activities in this study.</p>","PeriodicalId":39133,"journal":{"name":"Open Medicinal Chemistry Journal","volume":"11 ","pages":"38-53"},"PeriodicalIF":0.0000,"publicationDate":"2017-04-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874104501711010038","citationCount":"7","resultStr":"{\"title\":\"Synthesis of Oxadiazolyl, Pyrazolyl and Thiazolyl Derivatives of Thiophene-2-Carboxamide as Antimicrobial and Anti-HCV Agents.\",\"authors\":\"Ola H Rizk,&nbsp;Omaima G Shaaban,&nbsp;Abeer E Abdel Wahab\",\"doi\":\"10.2174/1874104501711010038\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Three series of pyrazole, thiazole and 1,3,4-oxadiazole, derivatives were synthesized starting from 5-amino-4-(hydrazinocarbonyl)-3-methylthiophene-2-carboxamide <b>(2)</b>.</p><p><strong>Methods: </strong>All compounds were investigated for their preliminary antimicrobial activity. They were proved to exhibit remarkable antimicrobial activity against <i>Pseudomonas aeruginosa</i> with insignificant activity towards Gram positive bacterial strains and fungi.</p><p><strong>Results: </strong><i>In-vitro</i> testing of the new compounds on hepatitis-C virus (HCV) replication in hepatocellular carcinoma cell line HepG2 infected with the virus utilizing the reverse transcription polymerase chain reaction technique (RT-PCR) generally showed inhibition of the replication of HCV RNA (-) strands at low concentration, while, eight compounds; <b>3a</b>, <b>6</b>, <b>7a</b>, <b>7b</b>, <b>9a</b>, <b>9b</b>, <b>10a</b> and <b>11b</b> proved to inhibit the replication of HCV RNA (+) and (-) strands at very low concentration range 0.08-0.36 μg/mL.</p><p><strong>Conclusion: </strong>Compounds <b>7b</b> and <b>11b</b> displayed the highest anti-HCV and antimicrobial activities in this study.</p>\",\"PeriodicalId\":39133,\"journal\":{\"name\":\"Open Medicinal Chemistry Journal\",\"volume\":\"11 \",\"pages\":\"38-53\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-04-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2174/1874104501711010038\",\"citationCount\":\"7\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Open Medicinal Chemistry Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1874104501711010038\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"Pharmacology, Toxicology and Pharmaceutics\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Open Medicinal Chemistry Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874104501711010038","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 7

摘要

前言:以5-氨基-4-(肼羰基)-3-甲基噻吩-2-羧酰胺(2)为起始原料,合成了吡唑、噻唑和1,3,4-恶二唑三个系列衍生物。方法:对所有化合物进行初步抑菌活性研究。对铜绿假单胞菌具有显著的抑菌活性,对革兰氏阳性菌株和真菌的抑菌活性不显著。结果:利用逆转录聚合酶链反应技术(RT-PCR)对新化合物在感染丙型肝炎病毒(HCV)的肝癌细胞株HepG2中进行体外复制检测,普遍显示在低浓度下抑制HCV RNA(-)链的复制,而8个化合物;在0.08 ~ 0.36 μg/mL的极低浓度范围内,3a、6、7a、7b、9a、9b、10a和11b均能抑制HCV RNA(+)和(-)链的复制。结论:化合物7b和11b的抗hcv和抗菌活性最高。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Synthesis of Oxadiazolyl, Pyrazolyl and Thiazolyl Derivatives of Thiophene-2-Carboxamide as Antimicrobial and Anti-HCV Agents.

Synthesis of Oxadiazolyl, Pyrazolyl and Thiazolyl Derivatives of Thiophene-2-Carboxamide as Antimicrobial and Anti-HCV Agents.

Synthesis of Oxadiazolyl, Pyrazolyl and Thiazolyl Derivatives of Thiophene-2-Carboxamide as Antimicrobial and Anti-HCV Agents.

Synthesis of Oxadiazolyl, Pyrazolyl and Thiazolyl Derivatives of Thiophene-2-Carboxamide as Antimicrobial and Anti-HCV Agents.

Introduction: Three series of pyrazole, thiazole and 1,3,4-oxadiazole, derivatives were synthesized starting from 5-amino-4-(hydrazinocarbonyl)-3-methylthiophene-2-carboxamide (2).

Methods: All compounds were investigated for their preliminary antimicrobial activity. They were proved to exhibit remarkable antimicrobial activity against Pseudomonas aeruginosa with insignificant activity towards Gram positive bacterial strains and fungi.

Results: In-vitro testing of the new compounds on hepatitis-C virus (HCV) replication in hepatocellular carcinoma cell line HepG2 infected with the virus utilizing the reverse transcription polymerase chain reaction technique (RT-PCR) generally showed inhibition of the replication of HCV RNA (-) strands at low concentration, while, eight compounds; 3a, 6, 7a, 7b, 9a, 9b, 10a and 11b proved to inhibit the replication of HCV RNA (+) and (-) strands at very low concentration range 0.08-0.36 μg/mL.

Conclusion: Compounds 7b and 11b displayed the highest anti-HCV and antimicrobial activities in this study.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Open Medicinal Chemistry Journal
Open Medicinal Chemistry Journal Pharmacology, Toxicology and Pharmaceutics-Pharmaceutical Science
CiteScore
4.40
自引率
0.00%
发文量
4
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信